Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy
NCT02027818
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Indocyanine Green
Sponsor
Jules Bordet Institute